• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems Patient Problem/Medical Problem (2688); Insufficient Information (4580)
Event Date 02/01/2018
Event Type  Injury  
Manufacturer Narrative
The patient alleges in a legal document that the patient "has been seriously and severely injured, was rendered sick, sore, lame and disabled, exacerbation of prior conditions, and suffered from, among other things, stroke, intellectual impairment, physical impairment, and permanent disabilities." medical assessment of the event concluded, information necessary to determine whether the coaguchek contributed to the stroke event was not provided.If further information is received a supplemental report will be filed.In general, strokes may be related to insufficient anticoagulation and other, anticoagulation independent conditions.The patient group with the need for anticoagulation is not treated curatively by anticoagulation.Anticoagulation only reduces the consequences and complications of the underlying disease, but risks remain.In case of insufficient anticoagulation, several reasons might have led to this (e.G.Not optimal therapeutic range due to co-morbidities, irregularities of medication intake/dosages, irregularities of life-style, co-medication, co-morbidities, etc.).No product is expected for return.Routine retention testing is performed.Test strip retention samples passed the internal inspection.Retention testing data is reviewed and appropriate actions are taken as needed.The investigation did not identify a product problem.The cause of the event could not be determined.Reporter occupation is lay user/patient.Unique identifier (udi): (b)(4).
 
Event Description
An allegation was received via a legal letter related to a patient having a stroke due to "incorrect and inaccurate" inr results from a coaguchek xs system with an unspecified serial number.The patient had a stroke in (b)(6) 2018.The date of event is an approximation as the actual date of the stroke was not provided.No specific patient information has been provided.The patients therapeutic range, medications and medical history were not provided.No specific details related to the event have been provided.No inr results have been provided.No information related to changes in vitamin k antagonist (vka) therapy has been provided.No diagnostic results related to the event have been provided.It is not known what type of stroke the patient had (ischemic/hemorrhagic) or the location of stroke.No information related to how the patient was treated has been provided.This mdr is being submitted in an abundance of caution.
 
Manufacturer Narrative
Patient code was updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key11401840
MDR Text Key234454206
Report Number1823260-2021-00644
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Type of Report Initial,Followup
Report Date 03/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue Number04625374160
Device Lot NumberASKU
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/01/2021
Initial Date FDA Received03/02/2021
Supplement Dates Manufacturer Received02/01/2021
Supplement Dates FDA Received03/22/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-